Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4082099
Max Phase: Preclinical
Molecular Formula: C48H74O15
Molecular Weight: 891.11
Molecule Type: Small molecule
Associated Items:
ID: ALA4082099
Max Phase: Preclinical
Molecular Formula: C48H74O15
Molecular Weight: 891.11
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@]4(O)[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2
Standard InChI: InChI=1S/C48H74O15/c1-11-25(2)42-28(5)17-18-46(63-42)23-34-20-33(62-46)16-15-27(4)41(60-39-22-37(55-10)43(31(8)58-39)61-38-21-36(54-9)40(49)30(7)57-38)26(3)13-12-14-32-24-56-48(53)44(50)29(6)19-35(45(51)59-34)47(32,48)52/h12-15,19,25-26,28,30-31,33-44,49-50,52-53H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40-,41-,42+,43-,44+,46+,47+,48+/m0/s1
Standard InChI Key: CCNVFFXHYWBOGH-XLEFBCLLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 891.11 | Molecular Weight (Monoisotopic): 890.5028 | AlogP: 4.92 | #Rotatable Bonds: 8 |
Polar Surface Area: 190.29 | Molecular Species: NEUTRAL | HBA: 15 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 9.91 | CX Basic pKa: | CX LogP: 5.64 | CX LogD: 5.63 |
Aromatic Rings: 0 | Heavy Atoms: 63 | QED Weighted: 0.19 | Np Likeness Score: 2.26 |
1. Gucchait A, Joardar N, Parida PK, Roy P, Mukherjee N, Dutta A, Yesuvadian R, SinhaBabu SP, Jana K, Misra AK.. (2018) Development of novel anti-filarial agents using carbamo(dithioperoxo)thioate derivatives., 143 [PMID:29207343] [10.1016/j.ejmech.2017.11.047] |
2. da Silva-Júnior EF, Leoncini GO, Rodrigues ÉES, Aquino TM, Araújo-Júnior JX.. (2017) The medicinal chemistry of Chikungunya virus., 25 (16): [PMID:28689975] [10.1016/j.bmc.2017.06.049] |
3. Vairoletti F, Medeiros A, Fontán P, Meléndrez J, Tabárez C, Salinas G, Franco J, Comini MA, Saldaña J, Jancik V, Mahler G, Saiz C.. (2019) Synthesis of bicyclic 1,4-thiazepines as novel anti-Trypanosoma brucei brucei agents., 10 (8): [PMID:31673311] [10.1039/C9MD00064J] |
Source(1):